How Patient-Centric Approaches Are Shaping The Future Of CGT

Emily Whitehead’s inspiring recovery from acute lymphoblastic leukemia (ALL) through CAR-T cell therapy exemplifies the transformative potential of cell and gene therapies (CGTs). Her remarkable journey, marked by resilience since age five, has fueled a global movement towards more patient-centered care. Central to this movement is the Emily Whitehead Foundation, led by George Eastwood, who champions the importance of incorporating the patient voice in treatment development.

This article explores Eastwood's vision for a patient-centric approach, emphasizing deeper understanding of patient needs, building trust, and integrating feedback. It also addresses the challenges in the CGT landscape, including early diagnosis, access to care, and high treatment costs, while highlighting strategies for fostering collaboration and innovation to overcome these hurdles and improve patient outcomes.